Association of monocyte chemoattractant protein 1 gene polymorphism with susceptibility to nonfamilial idiopathic dilated cardiomyopathy

Journal of Cardiology

Volumn 54, Issue 1, 2009, Pages 66-70

  Ogimoto, Akiyoshi ^a   Okayama, Hideki ^a   Nagai, Takayuki ^a   Ohtsuka, Tomoaki ^a   Suzuki, Jun ^a   Inoue, Katsuji ^a   Nishimura, Kazuhisa ^a   Shigematsu, Yuji ^a   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Higaki, Jitsuo ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dilated cardiomyopathy; Monocyte chemoattractant protein 1 (MCP 1); Polymorphism; Risk factor

Indexed keywords

CYTOSINE; GUANINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MCP 1 GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, DILATED; CHEMOKINE CCL2; CHILD; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 67650732670     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.04.001     Document Type: Article

References (18)

1. Kamisago M., Sharma S.D., DePalma S.R., Solomon S., Sharma P., McDonough B., Smoot L., Mullen M.P., Woolf P.K., Wigle D., Seidman J.G., and Seidman C.E. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343 (2000) 1688-1696
2. Sharkey S.W., Maron B.J., Nelson P., Parpart M., Maron M.S., and Bristow M.R. Adrenergic receptor polymorphisms in patients with stress (tako-tsubo) cardiomyopathy. J Cardiol 53 (2009) 53-57
3. Muir P., Nicholson F., Tilzey A.J., Signy M., English T.A., and Banatvala J.E. Chronic relapsing pericarditis and dilated cardiomyopathy. Serological evidence of persistent enterovirus infection. Lancet 1 (1989) 804-807
4. Caforio A.L., Keeling P.J., Zachara E., Mestroni L., Camerini F., Mann J.M., Bottazzo G.F., and McKenna W.J. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 344 (1994) 773-777
5. Limas C.J. Autoimmunity in dilated cardiomyopathy and the major histocompatibility complex. Int J Cardiol 54 (1996) 113-116
6. Lehmann M.H., Kühnert H., Müller S., and Sigusch H.H. Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy. Cytokine 10 (1998) 739-746
7. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259 (1999) 344-348
8. Tabara Y., Kohara K., Yamamoto Y., Igase M., Nakura J., Kondo I., and Miki T. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26 (2003) 677-683
9. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., and Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93 (1996) 841-842
10. Fuse K., Kodama M., Hanawa H., Okura Y., Ito M., Shiono T., Maruyama S., Hirono S., Kato K., Watanabe K., and Aizawa Y. Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin Exp Immunol 124 (2001) 346-352
11. Matsumori A., Furukawa Y., Hashimoto T., Yoshida A., Ono K., Shioi T., Okada M., Iwasaki A., Nishio R., Matsushima K., and Sasayama S. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol 29 (1997) 419-423
12. Aukrust P., Ueland T., Muller F., Andreassen A.K., Nordoy I., Aas H., Kjekshus J., Simonsen S., Froland S.S., and Gullestad L. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97 (1998) 1136-1143
13. Seino Y., Ikeda U., Sekiguchi H., Morita M., Konishi K., Kasahara T., and Shimada K. Expression of leukocyte chemotactic cytokines in myocardial tissue. Cytokine 7 (1995) 301-304
14. Jibiki T., Terai M., Shima M., Ogawa A., Hamada H., Kanazawa M., Yamamoto S., Oana S., and Kohno Y. Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease. Arthritis Rheum 44 (2001) 2211-2212
15. Szalai C., Kozma G.T., Nagy A., Bojszkó A., Krikovszky D., Szabó T., and Falus Al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 108 (2001) 375-381
16. Szalai C., Duba J., Prohaszka Z., Kalina A., Szabo T., Nagy B., Horvath L., and Csaszar A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1-2518 G/C genotype in CAD patients. Atherosclerosis 158 (2001) 233-239
17. Kim H.L., Lee D.S., Yang S.H., Lim C.S., Chung J.H., Kim S., Lee J.S., and Kim Y.S. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 40 (2002) 1146-1152
18. Omori K., Kazama J.J., Song J., Goto S., Takada T., Saito N., Sakatsume M., Narita I., and Gejyo F. Association of the MCP-1 gene polymorphism A-2518G with carpal-tunnel syndrome in hemodialysis patients. Amyloid 9 (2002) 175-182